formoterol fumarate inhalation solution

Generic: formoterol fumarate dihydrate

Labeler: ritedose pharmaceuticals, llc
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name formoterol fumarate inhalation solution
Generic Name formoterol fumarate dihydrate
Labeler ritedose pharmaceuticals, llc
Dosage Form SOLUTION
Routes
RESPIRATORY (INHALATION)
Active Ingredients

formoterol fumarate 20 ug/2mL

Manufacturer
Ritedose Pharmaceuticals, LLC

Identifiers & Regulatory

Product NDC 76204-030
Product ID 76204-030_459f276c-d771-4ae9-e063-6394a90a3476
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA216486
Listing Expiration 2026-12-31
Marketing Start 2025-03-14

Pharmacologic Class

Classes
adrenergic beta2-agonists [moa] beta2-adrenergic agonist [epc]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 76204030
Hyphenated Format 76204-030

Supplemental Identifiers

RxCUI
1246319
UNII
W34SHF8J2K

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name formoterol fumarate inhalation solution (source: ndc)
Generic Name formoterol fumarate dihydrate (source: ndc)
Application Number ANDA216486 (source: ndc)
Routes
RESPIRATORY (INHALATION)
source: ndc

Resolved Composition

Strengths
  • 20 ug/2mL
source: ndc
Packaging
  • 30 POUCH in 1 CARTON (76204-030-01) / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL
  • 60 POUCH in 1 CARTON (76204-030-02) / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL
source: ndc

Packages (2)

Ingredients (1)

formoterol fumarate (20 ug/2mL)

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["RESPIRATORY (INHALATION)"], "spl_id": "459f276c-d771-4ae9-e063-6394a90a3476", "openfda": {"unii": ["W34SHF8J2K"], "rxcui": ["1246319"], "spl_set_id": ["2d9bf685-8886-4865-834b-2748af124b79"], "manufacturer_name": ["Ritedose Pharmaceuticals, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 POUCH in 1 CARTON (76204-030-01)  / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL", "package_ndc": "76204-030-01", "marketing_start_date": "20250314"}, {"sample": false, "description": "60 POUCH in 1 CARTON (76204-030-02)  / 1 VIAL in 1 POUCH / 2 mL in 1 VIAL", "package_ndc": "76204-030-02", "marketing_start_date": "20250314"}], "brand_name": "Formoterol Fumarate Inhalation Solution", "product_id": "76204-030_459f276c-d771-4ae9-e063-6394a90a3476", "dosage_form": "SOLUTION", "pharm_class": ["Adrenergic beta2-Agonists [MoA]", "beta2-Adrenergic Agonist [EPC]"], "product_ndc": "76204-030", "generic_name": "formoterol fumarate dihydrate", "labeler_name": "Ritedose Pharmaceuticals, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Formoterol Fumarate Inhalation Solution", "active_ingredients": [{"name": "FORMOTEROL FUMARATE", "strength": "20 ug/2mL"}], "application_number": "ANDA216486", "marketing_category": "ANDA", "marketing_start_date": "20250314", "listing_expiration_date": "20261231"}